Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease? [PDF]
He CY +5 more
europepmc +1 more source
Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control study. [PDF]
Boon BDC +20 more
europepmc +1 more source
Memory Consolidation and ARIA in Individuals Receiving Anti-amyloid Monoclonal Antibodies. [PDF]
Haut MW +13 more
europepmc +1 more source
Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer's Disease. [PDF]
Strużyńska L +2 more
europepmc +1 more source
Passive amyloid-β immunotherapy in Alzheimer's disease: a multicellular clearance system beyond plaque removal. [PDF]
Zhan X +7 more
europepmc +1 more source
Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and plaque-clearing efficacy of a therapeutic anti-Aβ antibody. [PDF]
Vega MR +12 more
europepmc +1 more source
A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease. [PDF]
Chen T +13 more
europepmc +1 more source
Comparative effectiveness of multiple interventions for Alzheimer's disease on ABC syndromes and QoL: A Bayesian network meta-analysis. [PDF]
Gao F +5 more
europepmc +1 more source

